Developer docs
API playgroundTry for free, no card

Search company profiles

Agteria Biotech

Full company profile

uuid0002672

Namestring
Agteria Biotech
Legal namestring
Agteria Biotech AB
Websiteurl
agteria.com
Company typeenum
Private
Founded yearint
2023
Descriptiontext

Agteria Biotech AB is a Stockholm-based climate biotech startup founded in 2023 that develops enzyme inhibitor molecules designed to reduce enteric methane emissions from cattle and other livestock. The company's core technology targets the enzymatic processes in ruminant digestion that produce methane, with the stated aim of cutting 1% of global greenhouse gas emissions by 2035 through a single scalable product solution. The company is currently advancing its novel molecule through regulatory approval and safety studies rather than commercial sales.

Agteria's product portfolio is concentrated on a single core asset — a methane-reducing feed additive for cattle — positioned as a scalable and cost-effective alternative to existing enteric methane reduction approaches. The technology is described as a novel enzyme inhibitor architecture developed by a team with deep expertise in organic chemistry, biochemistry, and drug discovery. As of the available data, no patents or trademarks have been publicly disclosed, and the product is not yet commercially available.

Agteria is pre-revenue, with a planned revenue model based on one-time product licensing to livestock operations, likely distributed via enterprise field sales to large-scale cattle operations and agricultural enterprises following regulatory approval. The company has raised approximately €7.4 million to date across a €1.4M pre-seed round (Norrsken Launcher, March 2024) and a €6M seed round co-led by AgriZeroNZ and Industrifonden (February 2025), with participation from Mudcake. It operates with a lean 7-person team from Norrsken House in Stockholm and is pursuing visibility through the AHNTI EU 2026 Innovation Showcase.

Short descriptiontext

Agteria Biotech is a Stockholm-based climate biotech startup developing a novel enzyme inhibitor to reduce methane emissions from cattle, targeting livestock farmers and agricultural enterprises ahead of regulatory approval and commercialization.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersStockholm, Sweden
HQ citystring
Stockholm
HQ countrystring
Sweden
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
livestock feed additives, methane emission reduction, enzyme inhibitor technology, agricultural biotechnology, climate biotech solutions
Industry2 codes
PRIMARYAFADAAAL
Medicated & Functional Ruminant Feed (Ionophores, Buffers, Yeast/Probiotics, Mycotoxin Binders)
Agriculture & Food Production/Animal Feed Manufacturing/Ruminant Feed (Cattle, Sheep, Goats)
SECONDARYAFADAKAD
Enzymes & Digestibility Enhancers (Phytase, NSP enzymes)
Agriculture & Food Production/Animal Feed Manufacturing/Medicated & Functional Feed (Coccidiostats, Probiotics, Performance Additives)
NAICS code1 code
  • Animal Food Manufacturing3111
SIC code1 code
  • Agricultural Prod-Livestock & Animal Specialties200
Product category
Agricultural Biotechnology / Livestock Methane Reduction
No data
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Product Sales (Planned)
TypeOne Time License
Description

Agteria Biotech is in the pre-revenue stage, focused on developing its methane reduction product for cattle and obtaining regulatory approval. The company raised €1.4M in pre-seed funding (2024) and €6M in seed funding (2025) to support R&D, regulatory approvals, and safety studies. Revenue generation is expected through product sales to livestock operations once regulatory approval is secured.

siliconcanals.com
Marketing channels1 record

Each record includes

Title, Type, Stage, Description, Source

Cost components4 values
Technology or R&D, Personnel, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Agteria Biotech is developing a novel enzyme inhibitor molecule designed to reduce methane emissions from cattle by blocking the enzymatic pathways in ruminant digestion that produce methane. The product is intended as a scalable, cost-effective feed additive for livestock operations and is currently advancing through regulatory approval and safety studies before commercial launch.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Aims to reduce 1% of global emissions by 2035 through widespread adoption of methane reduction technology in livestock
Product overview1 text field

Agteria Biotech offers a single unified product focused on methane emission reduction for cattle. The core offering is a novel enzyme inhibitor molecule designed to block methane production in livestock, targeting agricultural greenhouse gas emissions as a climate change solution.

Product and service1 record
1Methane Emission Reduction Solution for Cattle
CategoryLivestock feed additive / Agricultural biotechnology
Description

A scalable, cost-effective enzyme inhibitor molecule designed to reduce methane emissions from cattle by targeting the enzymatic pathways in ruminant digestion that produce methane. The product is intended for cattle farmers and large-scale livestock operations and is currently undergoing regulatory approval and safety studies prior to commercialization.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Markets Bovaer (3-NOP), the leading approved feed additive for enteric methane reduction in dairy and beef cattle. Most directly comparable competitor — same target problem, same delivery mechanism (feed additive), same customer base (cattle farmers and dairy integrators).

TypeDirect peer
Description

Develops natural feed-additive formulations (citrus and garlic extracts) targeting enteric methane reduction in cattle. Closely comparable on mechanism class (feed-additive methane inhibitor) and target customer (dairy and beef producers).

TypeEmerging player
Description

Pioneers microbiome-engineering therapeutics that could be applied to modulate the rumen microbiome and reduce methane. Comparable as an emerging biotech using novel biology to address enteric methane in livestock.

TypeDirect peer
Description

Develops Brominata, an Asparagopsis-based (red seaweed) feed additive for enteric methane reduction in cattle. Comparable as a methane-reducing cattle feed additive approaching commercial deployment, with a different active ingredient than Agteria's enzyme inhibitor.

TypeDirect peer
Description

Commercializes Asparagopsis-based feed supplements (Methane Tamer) for cattle and sheep to cut enteric methane. Comparable on product class (feed-additive methane inhibitor) and customer segment (livestock industry).

TypeEmerging player
Description

Developing a methane-reducing vaccine for ruminants, taking a different mechanism (immunological) but targeting the same enteric methane problem in cattle and sheep. Comparable as a biotech pursuing novel biological routes to livestock methane reduction.

TypeEmerging player
Description

Develops wearable methane-capture devices for cattle rather than feed additives. Comparable as a cattle-methane-reduction startup serving the same dairy/beef customers, though addressing emissions capture post-production rather than at the digestive stage.

TypeEmerging player
Description

Australia-based developer of Asparagopsis-derived feed supplements for grazing livestock. Comparable as a methane-reducing feed-additive company targeting cattle and sheep producers in Oceania — overlapping with Agteria's market opportunity via AgriZeroNZ-backed channels.

TypeBroad incumbent
Description

Global animal nutrition and feed giant with growing interest in methane-reducing feed solutions and partnerships with companies like Bovaer's distributor. Comparable as a broad incumbent in the cattle feed market and a likely competitor, partner, or acquirer for emerging methane-reduction technologies.

TypeEmerging player
Description

Hawaii-based startup developing Asparagopsis seaweed-based feed additives to reduce enteric methane in livestock. Comparable as an early-stage methane-reducing feed-additive company targeting the same cattle and dairy industry opportunity.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors4 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Agteria Biotech

Agricultural Biotechnology / Livestock Methane Reductionagteria.com

Agteria Biotech is a Stockholm-based climate biotech startup developing a novel enzyme inhibitor to reduce methane emissions from cattle, targeting livestock farmers and agricultural enterprises ahead of regulatory approval and commercialization.

What Agteria Biotech does

Agteria Biotech AB is a Stockholm-based climate biotech startup founded in 2023 that develops enzyme inhibitor molecules designed to reduce enteric methane emissions from cattle and other livestock. The company's core technology targets the enzymatic processes in ruminant digestion that produce methane, with the stated aim of cutting 1% of global greenhouse gas emissions by 2035 through a single scalable product solution. The company is currently advancing its novel molecule through regulatory approval and safety studies rather than commercial sales.

Agteria's product portfolio is concentrated on a single core asset — a methane-reducing feed additive for cattle — positioned as a scalable and cost-effective alternative to existing enteric methane reduction approaches. The technology is described as a novel enzyme inhibitor architecture developed by a team with deep expertise in organic chemistry, biochemistry, and drug discovery. As of the available data, no patents or trademarks have been publicly disclosed, and the product is not yet commercially available.

Agteria is pre-revenue, with a planned revenue model based on one-time product licensing to livestock operations, likely distributed via enterprise field sales to large-scale cattle operations and agricultural enterprises following regulatory approval. The company has raised approximately €7.4 million to date across a €1.4M pre-seed round (Norrsken Launcher, March 2024) and a €6M seed round co-led by AgriZeroNZ and Industrifonden (February 2025), with participation from Mudcake. It operates with a lean 7-person team from Norrsken House in Stockholm and is pursuing visibility through the AHNTI EU 2026 Innovation Showcase.

Agteria Biotech firmographics

Firmographics
Name
Agteria Biotech
Legal name
Agteria Biotech AB
Website
https://agteria.com
Company type
Private
Founded year
2023
Operating status
Operating
Headcount range
11–50 employees
Short description
Agteria Biotech is a Stockholm-based climate biotech startup developing a novel enzyme inhibitor to reduce methane emissions from cattle, targeting livestock farmers and agricultural enterprises ahead of regulatory approval and commercialization.
Ownership category
akta.pro rank

Agteria Biotech industry classification

Industry
Product category
Agricultural Biotechnology / Livestock Methane Reduction
NAICS
Animal Food Manufacturing (3111)
SIC
Agricultural Prod-Livestock & Animal Specialties (200)
akta.pro industry
PRIMARYAFADAAAL
Medicated & Functional Ruminant Feed (Ionophores, Buffers, Yeast/Probiotics, Mycotoxin Binders)
Agriculture & Food Production/Animal Feed Manufacturing/Ruminant Feed (Cattle, Sheep, Goats)
SECONDARYAFADAKAD
Enzymes & Digestibility Enhancers (Phytase, NSP enzymes)
Agriculture & Food Production/Animal Feed Manufacturing/Medicated & Functional Feed (Coccidiostats, Probiotics, Performance Additives)

Keywords

  • Livestock feed additives
  • Methane emission reduction
  • Enzyme inhibitor technology
  • Agricultural biotechnology
  • Climate biotech solutions

Where Agteria Biotech is headquartered

Location

Headquarters

HQ city
Stockholm
HQ country
Sweden
HQ region
Europe

Offices1 record

Markets served

Agteria Biotech business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales

Revenue model

  1. Product Sales (Planned): Agteria Biotech is in the pre-revenue stage, focused on developing its methane reduction product for cattle and obtaining regulatory approval. The company raised €1.4M in pre-seed funding (2024) and €6M in seed funding (2025) to support R&D, regulatory approvals, and safety studies. Revenue generation is expected through product sales to livestock operations once regulatory approval is secured.

Go-to-market motion1 record

Marketing channels1 record

Agteria Biotech product offering

Product offering

Core offering

Agteria Biotech is developing a novel enzyme inhibitor molecule designed to reduce methane emissions from cattle by blocking the enzymatic pathways in ruminant digestion that produce methane. The product is intended as a scalable, cost-effective feed additive for livestock operations and is currently advancing through regulatory approval and safety studies before commercial launch.

Product overview

Agteria Biotech offers a single unified product focused on methane emission reduction for cattle. The core offering is a novel enzyme inhibitor molecule designed to block methane production in livestock, targeting agricultural greenhouse gas emissions as a climate change solution.

Differentiator

Problem solved

Functional benefit

Products and services

  • Methane Emission Reduction Solution for Cattle A scalable, cost-effective enzyme inhibitor molecule designed to reduce methane emissions from cattle by targeting the enzymatic pathways in ruminant digestion that produce methane. The product is intended for cattle farmers and large-scale livestock operations and is currently undergoing regulatory approval and safety studies prior to commercialization.

Quantifiable outcome

  • Aims to reduce 1% of global emissions by 2035 through widespread adoption of methane reduction technology in livestock

Companies that use Agteria Biotech

Customer profile

Segments1 record

Ideal customer profiles1 record

Agteria Biotech technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

Agteria Biotech partnerships and signals

Strategic signal

Scale indicators4 records

Recent moves5 records

Expansion highlights5 records

Agteria Biotech competitors and assessment

Company assessment

Direct peers

  • DSM-Firmenich (Bovaer): Markets Bovaer (3-NOP), the leading approved feed additive for enteric methane reduction in dairy and beef cattle. Most directly comparable competitor — same target problem, same delivery mechanism (feed additive), same customer base (cattle farmers and dairy integrators).
  • Mootral: Develops natural feed-additive formulations (citrus and garlic extracts) targeting enteric methane reduction in cattle. Closely comparable on mechanism class (feed-additive methane inhibitor) and target customer (dairy and beef producers).
  • Blue Ocean Barns: Develops Brominata, an Asparagopsis-based (red seaweed) feed additive for enteric methane reduction in cattle. Comparable as a methane-reducing cattle feed additive approaching commercial deployment, with a different active ingredient than Agteria's enzyme inhibitor.
  • CH4 Global: Commercializes Asparagopsis-based feed supplements (Methane Tamer) for cattle and sheep to cut enteric methane. Comparable on product class (feed-additive methane inhibitor) and customer segment (livestock industry).

Emerging players

  • Eligo Bioscience: Pioneers microbiome-engineering therapeutics that could be applied to modulate the rumen microbiome and reduce methane. Comparable as an emerging biotech using novel biology to address enteric methane in livestock.
  • ArkeaBio: Developing a methane-reducing vaccine for ruminants, taking a different mechanism (immunological) but targeting the same enteric methane problem in cattle and sheep. Comparable as a biotech pursuing novel biological routes to livestock methane reduction.
  • Zelp (Zero Emissions Livestock Project): Develops wearable methane-capture devices for cattle rather than feed additives. Comparable as a cattle-methane-reduction startup serving the same dairy/beef customers, though addressing emissions capture post-production rather than at the digestive stage.
  • Synergraze: Australia-based developer of Asparagopsis-derived feed supplements for grazing livestock. Comparable as a methane-reducing feed-additive company targeting cattle and sheep producers in Oceania — overlapping with Agteria's market opportunity via AgriZeroNZ-backed channels.
  • Symbrosia: Hawaii-based startup developing Asparagopsis seaweed-based feed additives to reduce enteric methane in livestock. Comparable as an early-stage methane-reducing feed-additive company targeting the same cattle and dairy industry opportunity.

Broad incumbents

  • Cargill: Global animal nutrition and feed giant with growing interest in methane-reducing feed solutions and partnerships with companies like Bovaer's distributor. Comparable as a broad incumbent in the cattle feed market and a likely competitor, partner, or acquirer for emerging methane-reduction technologies.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

Agteria Biotech financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Agteria Biotech leadership team

Management profile

Number of profiles

Profiles7 records

Agteria Biotech funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Agteria Biotech M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Agteria Biotech

What does Agteria Biotech do?

Agteria Biotech is developing a novel enzyme inhibitor molecule designed to reduce methane emissions from cattle by blocking the enzymatic pathways in ruminant digestion that produce methane. The product is intended as a scalable, cost-effective feed additive for livestock operations and is currently advancing through regulatory approval and safety studies before commercial launch.

Is Agteria Biotech a public or private company?

Agteria Biotech is a private company. It is classified as venture growth investor backed and is currently operating.

When was Agteria Biotech founded?

Agteria Biotech was founded in 2023. It employs 11 to 50 people.

Where is Agteria Biotech based?

Agteria Biotech is headquartered in Stockholm, Sweden, in the Europe region.

How does Agteria Biotech make money?

One revenue line is on record: product Sales (Planned).

Who are Agteria Biotech's main competitors?

Direct peers on record are DSM-Firmenich (Bovaer), Mootral, Blue Ocean Barns and CH4 Global. Emerging players are Eligo Bioscience, ArkeaBio, Zelp (Zero Emissions Livestock Project), Synergraze and Symbrosia. Cargill is listed as a broad incumbent.

Does Agteria Biotech have an API?

No public API is recorded for Agteria Biotech.

What industry is Agteria Biotech in?

Agteria Biotech's product category is Agricultural Biotechnology / Livestock Methane Reduction. Its primary akta.pro industry code is AFADAAAL, Medicated & Functional Ruminant Feed (Ionophores, Buffers, Yeast/Probiotics, Mycotoxin Binders), with a secondary code of AFADAKAD, Enzymes & Digestibility Enhancers (Phytase, NSP enzymes). Its NAICS code is 3111 and its SIC code is 200.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
All About FeedAHNTI EU announces 2026 Innovation Showcase finalistsAHNTI EU has announced the 18 finalists for its 2026 Innovation Showcase, a curated selection of early-stage companies in biopharma, nutrition, technology, and diagnostics identified as the "ones to watch" in animal health. The finalists will pitch live on 2 March 2026 at Convene St Paul's in London to an audience of over 850 industry leaders, investors, and strategic partners. The 18 companies span four categories: Biopharma (BioAZ, Modulant Bioscience, NanoVet Biotech, Pasture Biosciences), Nutrition (Agteria Biotech, NanosVet, Pet Diet Plans, PhageLab), Technology (Athian, MariHealth Solutions, Photon Therapeutics, Vet Vision AI), and Diagnostics (PrediPet, InsituGen, Pictor, Pronova).GlobalaginvestingSwedish Biotech Secures €6M in Seed Round for Methane-Reducing Cattle Feed SupplementAgteria Biotech, a Stockholm-based agricultural biotech startup focused on net-zero solutions, has secured €6 million in seed funding led by Industrifonden and Norrsken, bringing its total fundraising to €7.4 million. The proceeds will support scaling its patent-pending AB-01 methane-reducing cattle feed additive through regulatory approval, production expansion, and commercial rollouts targeting beef, dairy, and animal feed markets. The company, founded in 2023, is initially targeting Europe, South America, New Zealand, and Australia where sustainability regulations and industry commitments are driving adoption.Tech.euSwedish startup Agteria Biotech raises €6M to reduce methane emissions from cattleSwedish startup Agteria Biotech raised €6 million in seed funding to develop a molecule that reduces methane emissions from cattle. The company aims for a 1% global greenhouse gas reduction, with the funding enabling regulatory approval and safety studies.Silicon CanalsSweden’s Agteria raises €6M to reduce methane emissions from cattleAgteria Biotech, a Stockholm-based company, raised €6M in a seed round co-led by Industrifonden and AgriZeroNZ. The funding will support regulatory approval for its patent-pending cattle methane-reducing product, AB-01. The company aims to make agriculture net zero.Tech Funding NewsClimate crisis: Why this Swedish biotech bagged €6M to block methane from cattle? — TFNSwedish biotech Agteria Biotech raised €6 million in seed funding co-led by Industrifonden and AgriZeroNZ to accelerate its methane-reducing cattle solution. The company aims to cut 1% of global greenhouse gas emissions, with funding supporting regulatory approval and safety studies.Animalagtecheurope19 Start-Ups to Watch at Animal AgTechThe Animal AgTech Innovation Summit in Amsterdam on October 9-10 will showcase 19 start-ups addressing animal health, emissions, biodiversity and feed safety, including Agteria Biotech, Biofractal, Dyneval, Rumin8 and Smartbell. Two pitch showcases will be judged by BETAGRO VENTURES, SANDWATER and PELICAN AG, while the Global Dairy Challenge winner will be announced live and awarded €100,000.Techarenan NewsAgteria Biotech secures €1.4M from Norrsken Launcher to reduce methane emissions from livestockAgteria Biotech secured €1.4 million in a pre-seed funding round led by Norrsken Launcher to commercialize its enzyme inhibitor technology for reducing livestock methane emissions. The startup, founded on research from Stockholm’s Royal Institute of Technology, aims to overcome scalability and cost hurdles associated with previous solutions like red seaweed. The company plans to use the funds for in-vivo experiments and increased production, having already secured letters of intent with major European players.